Positron's Attrius PET scanner sold to Gramercy Cardiac Diagnostic Services

Positron Corporation (OTCBB:POSC) a molecular imaging solutions company focused on Nuclear Cardiology, announced today the sale of its Attrius^TM PET scanner to Manhattan based, Gramercy Cardiac Diagnostic Services, owned by prominent New York City cardiologist, Dr. Peter Rentrop.

“We are proud to sell Positron’s newly released AttriusTM PET scanner to Dr. Rentrop. We appreciate his confidence in Positron Corporation in purchasing multiple systems to date.”

The Attrius™ is the only PET scanner on the market optimized for myocardial perfusion imaging. The Attrius™ has several specialized features making it the scanner of choice for nuclear cardiologist’s who value high quality PET imagery and cardiovascular specific interpretation tools, assisting in accurately assessing the patient’s condition.

Joseph Oliverio, Chief Technology Officer of Positron states, “We are proud to sell Positron’s newly released Attrius^TM PET scanner to Dr. Rentrop. We appreciate his confidence in Positron Corporation in purchasing multiple systems to date.” Oliverio further stated, “Positron has the ideal solution for thousands of cardiology groups looking to improve their diagnostic accuracy at an affordable price.”